Literature DB >> 6862637

The role of antibodies against alpha-toxin and teichoic acid in the diagnosis of staphylococcal infections.

I G Julander, M Granström, S A Hedström, R Möllby.   

Abstract

An enzyme-linked immunosorbent assay (ELISA) was used with purified alpha-toxin and teichoic acid preparations to measure the IgG and IgM response in Staphylococcus aureus infections. After determining antibodies in a normal population, cut-off levels were set for all age groups. ELISA with alpha-toxin was more sensitive than the antistaphylolysin neutralization test (ASTA). Determining IgM antibodies with the two antigens was found to be of limited diagnostic value. Positive IgG titers against alpha-toxin were found in 21 of 27 patients (78%) with endocarditis, 11 of 14 (79%) with complicated septicemia, eight of 20 (40%) with uncomplicated septicemia and in 12 of 22 (54%) with chronic osteomyelitis. The IgG responses to teichoic acid and alpha-toxin were somewhat different when measured by ELISA, and the parallel performance of the two assays resulted in improved serological diagnostics. The number of positive patients increased to 89%, 86%, 65% and 64%, respectively, in the four groups with a diagnostic specificity of 93%. In septicemic staphylococcal infections, the diagnosis could be established in all patients (28 of 28) with adequately spaced paired samples.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6862637     DOI: 10.1007/bf01641071

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  15 in total

1.  "NORMAL" VALUES OF ANTISTREPTOLYSIN AND ANTISTAPHYLOLYSIN TITRES AS STUDIED OVER 4 1/2 YEARS IN THE SERA OF HEALTHY BLOOD DONORS.

Authors:  R INGESTAD; S WINBLAD
Journal:  Acta Pathol Microbiol Scand       Date:  1963

2.  A microplate method of enzyme-linked immunosorbent assay and its application to malaria.

Authors:  A Voller; D Bidwell; G Huldt; E Engvall
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408

3.  Some biological properties of purified staphylococcal haemolysins.

Authors:  T Wadström; R Möllby
Journal:  Toxicon       Date:  1972-08       Impact factor: 3.033

4.  General and local antibiotic treatment of chronic osteomyelitis.

Authors:  S A Hedström
Journal:  Scand J Infect Dis       Date:  1969

5.  Teichoic acid serologic diagnosis of staphylococcal endocarditis. Use of gel diffusion and counterimmunoelectrophoretic methods.

Authors:  J G Nagel; C U Tuazon; T A Cardella; J N Sheagren
Journal:  Ann Intern Med       Date:  1975-01       Impact factor: 25.391

6.  Recurrent Staphylococcal furunculosis: lymphocyte subsets and plasma immunoglobulins.

Authors:  K Valmin; T Hallberg; S A Hedström
Journal:  Scand J Infect Dis       Date:  1982

7.  Solid-phase radioimmunoassay for immunoglobulin G Staphylococcus aureus antibody in serious staphylococcal infection.

Authors:  L J Wheat; R B Kohler; A White
Journal:  Ann Intern Med       Date:  1978-10       Impact factor: 25.391

8.  Teichoic acid antibodies in chronic staphylococcal osteomyelitis.

Authors:  P A Mackowiak; J W Smith
Journal:  Ann Intern Med       Date:  1978-10       Impact factor: 25.391

9.  Effects of staphylococcal alpha-, beta-, delta-, and gamma-hemolysins on human diploid fibroblasts and HeLa cells: evaluation of a new quantitative as say for measuring cell damage.

Authors:  M Thelestam; R Möllby; T Wadström
Journal:  Infect Immun       Date:  1973-12       Impact factor: 3.441

10.  Septicemia I. A prospective study on etiology, underlying factors and sources of infection.

Authors:  M Svanbom
Journal:  Scand J Infect Dis       Date:  1979
View more
  17 in total

1.  Immune modulation with a staphylococcal preparation in fibromyalgia/chronic fatigue syndrome: relation between antibody levels and clinical improvement.

Authors:  O Zachrisson; P Colque-Navarro; C G Gottfries; B Regland; R Möllby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-20       Impact factor: 3.267

2.  High levels of antibody to panton-valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infection.

Authors:  Christina R Hermos; Pauline Yoong; Gerald B Pier
Journal:  Clin Infect Dis       Date:  2010-10-14       Impact factor: 9.079

3.  Levels of antibody against 11 Staphylococcus aureus antigens in a healthy population.

Authors:  Patricia Colque-Navarro; Gunnar Jacobsson; Rune Andersson; Jan-Ingmar Flock; Roland Möllby
Journal:  Clin Vaccine Immunol       Date:  2010-05-05

4.  Serum antibodies to pneumolysin in patients with pneumonia.

Authors:  K Kanclerski; S Blomquist; M Granström; R Möllby
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

5.  Prospective study of serum staphylococcal antibodies in cystic fibrosis.

Authors:  A E Hollsing; M Granström; B Strandvik
Journal:  Arch Dis Child       Date:  1987-09       Impact factor: 3.791

6.  IgG subclass distribution of antibodies against S. aureus teichoic acid and alpha-toxin in normal and immunodeficient donors.

Authors:  L Hammarström; M Granström; V Oxelius; M A Persson; C I Smith
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

7.  Antistaphylococcal antibodies in cystic fibrosis.

Authors:  B Strandvik; A Hollsing; R Möllby; M Granström
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

8.  Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia.

Authors:  Brook E Ragle; Juliane Bubeck Wardenburg
Journal:  Infect Immun       Date:  2009-04-20       Impact factor: 3.441

9.  Enzyme-linked immunosorbent assay to evaluate the immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humans.

Authors:  M Granström; B Wretlind; B Markman; S Cryz
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

10.  Diagnosis of pneumococcal pneumonia by enzyme-linked immunosorbent assay of antibodies to pneumococcal hemolysin (pneumolysin).

Authors:  M Kalin; K Kanclerski; M Granström; R Möllby
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.